Human Prokineticin 2 ELISA Kit (Colorimetric)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-06923
Key Product Details
Sample Type & Volume Required Per Well
Serum, Plasma, Cell supernatant (100 ul)
Sensitivity
0.19 ng/mL
Assay Range
0.31 - 20 ng/mL
Product Specifications
Assay Type
Sandwich-ELISA
Kit Type
ELISA Kit (Colorimetric)
Reactivity
Human
Specificity
This kit recognizes Human Prokineticin 2 in samples. No significant cross-reactivity or interference between Human Prokineticin 2 and analogues was observed.
Precision
Intra-Assay Precision (Precision within an assay) 4.82
Inter-Assay Precision (Precision between assays) 5.67
Recovery for Human Prokineticin 2 ELISA Kit (Colorimetric)
Recovery
87-112 %
Linearity
Scientific Data Images for Human Prokineticin 2 ELISA Kit (Colorimetric)
ELISA: Human Prokineticin 2 ELISA Kit (Colorimetric) [NBP3-06923] -
ELISA: Human Prokineticin 2 ELISA Kit (Colorimetric) [NBP3-06923] - Standard Curve ReferenceKit Contents for Human Prokineticin 2 ELISA Kit (Colorimetric)
- Biotinylated Detection Ab Diluent
- Concentrated Biotinylated Detection Ab (100x)
- Concentrated HRP Conjugate (100x)
- Concentrated Wash Buffer (25x)
- HRP Conjugate Diluent
- Micro ELISA Plate (Dismountable)
- Plate Sealer
- Product Manual
- Reference Standard
- Sample Diluent
- Stop Solution
- Substrate Reagent
Preparation and Storage
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Storage of components varies. See protocol for specific instructions.
Background: Prokineticin 2
Long Name
Prokineticin-2
Alternate Names
BV8, PROK2, Protein Bv8 homolog
Gene Symbol
PROK2
Additional Prokineticin 2 Products
Product Documents for Human Prokineticin 2 ELISA Kit (Colorimetric)
Product Specific Notices for Human Prokineticin 2 ELISA Kit (Colorimetric)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. ELISA Kits are guaranteed for 6 months from date of receipt.
Loading...
Loading...
Loading...
Loading...